CDT - CDT Equity Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.81 0.79 (20.73%)	---	0.01 (0.22%)	0.2 (4.55%)	-0.04 (-1.18%)	0.45 (11.97%)	0.54 (13.3%)	0.54 (13.3%)

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -5.46
Diluted EPS:: -5.46
Basic P/E:: -0.8425
Diluted P/E:: -0.8425
RSI(14) 1m:: 47.73
VWAP:: 4.56
RVol:: 0.1801

Events

Period	Kind	Movement	Occurred At
10m	Price increase 10m	4.5 +0.2 (+4.68%)	Oct 15 17:25
10m	Price decrease 10m	4.17 -0.13 (-3.02%)	Oct 15 17:18
1m	Price decrease 1m	4.5 -0.09 (-1.96%)	Oct 15 17:02
1m	Price increase 1m	4.59 +0.24 (+5.52%)	Oct 15 17:01
10m	Price increase 10m	4.59 +0.26 (+6.0%)	Oct 15 17:01